Empirical Study on the Transparency of Security Risk Information in Chinese Listed Pharmaceutical Enterprises Based on the ANP-DS Method

<table class="table-group" id="tab5"><tr><td><table class="table"><tr><td class="thead-hr" colspan="6"><hr/></td></tr><tr class="thead"><td class="align_left">Survey sample subject</td><td class="align_center">Cronbach’s alpha</td><td class="align_center">KMO</td><td class="align_center">Bartlett</td><td class="align_center">df</td><td class="align_center">Sig</td></tr><tr><td class="thead-hr" colspan="6"><hr/></td></tr><tr><td class="align_left">Government</td><td class="align_center">0.921</td><td class="align_center">0.926</td><td class="align_center">15260.314</td><td class="align_center">65</td><td class="align_center">0.000</td></tr><tr><td class="align_left">Enterprise</td><td class="align_center">0.904</td><td class="align_center">0.917</td><td class="align_center">5613.276</td><td class="align_center">24</td><td class="align_center">0.000</td></tr><tr class="table-tr"><td colspan="6"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Reliability and validity test of the survey sampling table.</div>

Journal of Healthcare Engineering

tab5

Table 5

Table 5: Empirical Study on the Transparency of Security Risk Information in Chinese Listed Pharmaceutical Enterprises Based on the ANP-DS Method 